Evidence map›Paper›PMID 42787190›Full record

ArticleFrontiers in psychiatry2026

Autistic traits and obsessive-compulsive symptom severity: a retrospective six-month follow-up study.

Yunus Akkeçili, Şebnem Pırıldar

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yunus AkkeçiliDepartment of Psychiatry, Dinar State Hospital, Afyonkarahisar, Türkiye.
Şebnem PırıldarDepartment of Psychiatry, Faculty of Medicine, Ege University, İzmir, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autistic traits have been increasingly associated with obsessive-compulsive disorder (OCD), yet their influence on longitudinal symptom severity and treatment-related change remains poorly understood. This retrospective longitudinal study included 38 adults with DSM-5 OCD who completed six months of guideline-based pharmacological treatment. Obsessive-compulsive symptom severity was assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) at baseline, one month, and six months. Autistic traits were evaluated at the six-month follow-up using the Autism Spectrum Quotient (AQ). Linear mixed-effects models served as the primary analyses, while repeated-measures analyses of covariance were performed as sensitivity analyses. Exploratory analyses examined the contribution of individual AQ subscales. Higher autistic trait levels were independently associated with persistently greater OCD symptom severity across the six-month follow-up, whereas the rate of treatment-related improvement did not differ according to autistic trait levels. This association was primarily driven by compulsive rather than obsessive symptoms. Exploratory analyses further identified social skills and attention switching as the AQ dimensions most strongly associated with overall OCD severity and compulsive symptom burden, whereas attention to detail was not significantly associated with symptom severity. These findings suggest that autistic traits represent stable markers of greater clinical burden in OCD without necessarily conferring poorer pharmacological treatment responsiveness. The results further support a dimensional conceptualization of autistic traits and highlight social functioning as a potentially important contributor to OCD symptom burden.

Indexed as

autistic traitsbroader autism phenotypecompulsionslongitudinal studyobsessive–compulsive disorder

Identifiers

PMID42787190
PMCPMC13601252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.